CAPTRUST Financial Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,597
| Closed | -$36K | – | 4216 |
|
|
2022
Q2 | $36K | Buy |
2,597
+384
| +17% | +$5.32K | ﹤0.01% | 3004 |
|
|
2022
Q1 | $43K | Sell |
2,213
-449
| -17% | -$8.72K | ﹤0.01% | 2907 |
|
|
2021
Q4 | $43K | Buy |
2,662
+788
| +42% | +$12.7K | ﹤0.01% | 2777 |
|
|
2021
Q3 | $52K | Hold |
1,874
| – | – | ﹤0.01% | 2552 |
|
|
2021
Q2 | $56K | Sell |
1,874
-500
| -21% | -$14.9K | ﹤0.01% | 2446 |
|
|
2021
Q1 | $66K | Buy |
2,374
+632
| +36% | +$17.6K | ﹤0.01% | 2246 |
|
|
2020
Q4 | $49K | Hold |
1,742
| – | – | ﹤0.01% | 1839 |
|
|
2020
Q3 | $44K | Hold |
1,742
| – | – | ﹤0.01% | 1681 |
|
|
2020
Q2 | $44K | Buy |
+1,742
| New | +$44K | ﹤0.01% | 1667 |
|
|
2019
Q4 | – | Sell |
-200
| Closed | -$3K | – | 1872 |
|
|
2019
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 1760 |
|
|
2019
Q2 | $3K | Hold |
200
| – | – | ﹤0.01% | 1762 |
|
|
2019
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 1651 |
|
|
2018
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 1402 |
|
|
2018
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 1367 |
|
|
2018
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 1332 |
|
|
2018
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 1143 |
|
|
2017
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 1084 |
|
|
2017
Q3 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 479 |
|